| Primary |
| Crohn's Disease |
51.6% |
| Rheumatoid Arthritis |
33.3% |
| Hypertension |
2.7% |
| Pain |
2.2% |
| Depression |
1.2% |
| Osteoporosis |
1.1% |
| Prophylaxis |
1.0% |
| Vitamin Supplementation |
0.8% |
| Supplementation Therapy |
0.7% |
| Gastrooesophageal Reflux Disease |
0.7% |
| Psoriatic Arthropathy |
0.7% |
| Anxiety |
0.6% |
| Diabetes Mellitus |
0.6% |
| Asthma |
0.6% |
| Hypothyroidism |
0.5% |
| Colitis Ulcerative |
0.5% |
| Nausea |
0.4% |
| Insomnia |
0.4% |
| Ankylosing Spondylitis |
0.4% |
| Migraine |
0.3% |
|
| Crohn's Disease |
8.9% |
| Drug Ineffective |
8.2% |
| Fatigue |
7.1% |
| Rash |
7.0% |
| Vomiting |
5.8% |
| Pyrexia |
5.4% |
| Pneumonia |
4.9% |
| Diarrhoea |
4.8% |
| Psoriasis |
4.8% |
| Weight Decreased |
4.5% |
| Abdominal Pain |
4.4% |
| Pain |
4.3% |
| Injection Site Pain |
4.2% |
| Malaise |
4.2% |
| Nausea |
4.1% |
| Frequent Bowel Movements |
3.9% |
| Urinary Tract Infection |
3.7% |
| Herpes Zoster |
3.5% |
| Nasopharyngitis |
3.3% |
| Pregnancy |
3.1% |
|
| Secondary |
| Crohn's Disease |
36.5% |
| Rheumatoid Arthritis |
34.6% |
| Product Used For Unknown Indication |
3.4% |
| Pain |
3.3% |
| Hypertension |
3.1% |
| Psoriatic Arthropathy |
2.5% |
| Ankylosing Spondylitis |
1.7% |
| Depression |
1.6% |
| Vitamin Supplementation |
1.5% |
| Osteoporosis |
1.3% |
| Colitis Ulcerative |
1.3% |
| Asthma |
1.2% |
| Spondylitis |
1.2% |
| Supplementation Therapy |
1.2% |
| Type 2 Diabetes Mellitus |
1.2% |
| Prophylaxis |
1.0% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Fibromyalgia |
0.9% |
| Anxiety |
0.8% |
| Chronic Obstructive Pulmonary Disease |
0.8% |
|
| Crohn's Disease |
8.9% |
| Thrombosis |
8.7% |
| Pneumonia |
7.3% |
| Vomiting |
6.4% |
| Pyrexia |
6.3% |
| Weight Decreased |
6.3% |
| Rheumatoid Arthritis |
5.7% |
| Rash |
5.0% |
| Cellulitis |
4.7% |
| Pain |
4.7% |
| Fatigue |
4.3% |
| Pregnancy |
4.3% |
| Urinary Tract Infection |
4.2% |
| Psoriasis |
3.8% |
| Abdominal Pain |
3.7% |
| Diarrhoea |
3.7% |
| Sepsis |
3.5% |
| Abscess |
3.0% |
| Herpes Zoster |
2.8% |
| Upper Respiratory Tract Infection |
2.8% |
|
| Concomitant |
| Crohn's Disease |
30.5% |
| Product Used For Unknown Indication |
18.1% |
| Rheumatoid Arthritis |
15.0% |
| Inflammatory Bowel Disease |
14.6% |
| Vitamin Supplementation |
4.0% |
| Abdominal Pain |
2.5% |
| Pain |
2.1% |
| Psoriatic Arthropathy |
1.5% |
| Mineral Supplementation |
1.4% |
| Diabetes Mellitus |
1.3% |
| Osteoporosis |
1.1% |
| Small Intestinal Obstruction |
1.1% |
| Anxiety |
1.0% |
| Depression |
0.9% |
| Diarrhoea |
0.9% |
| Intestinal Resection |
0.9% |
| Contraception |
0.8% |
| Nasopharyngitis |
0.8% |
| Drug Use For Unknown Indication |
0.7% |
| Hypertension |
0.7% |
|
| Crohn's Disease |
34.6% |
| Rheumatoid Arthritis |
7.1% |
| Drug Ineffective |
6.7% |
| Rash |
6.3% |
| Therapeutic Response Decreased |
5.9% |
| Inflammatory Bowel Disease |
5.1% |
| Urinary Tract Infection |
3.5% |
| Application Site Dermatitis |
3.1% |
| Small Intestinal Obstruction |
3.1% |
| Small Intestinal Stenosis |
3.1% |
| Pain |
2.8% |
| Pain In Extremity |
2.4% |
| Weight Decreased |
2.4% |
| Abdominal Pain |
2.0% |
| Clostridial Infection |
2.0% |
| Hyponatraemia |
2.0% |
| Ileal Stenosis |
2.0% |
| Malaise |
2.0% |
| Nephrolithiasis |
2.0% |
| Sinusitis |
2.0% |
|
| Interacting |
| Rheumatoid Arthritis |
62.5% |
| Chronic Obstructive Pulmonary Disease |
12.5% |
| Inflammation |
12.5% |
| Seasonal Allergy |
12.5% |
|
| Rheumatoid Arthritis |
100.0% |
|
